基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
COVID-19 pandemic has shown greater severity in people with co-morbidities;diabetes being the leading cause of higher mortality rates in COVID-19 patients. Besides compromised immunity, there are other factors that make diabetics more prone to SARS-CoV-2 infection. To date, there is no clinically proven treatment for this disease, but fortunately there are several reports of vaccines in different stages of development. This review compiles some commonly used anti-diabetic drugs and their probable efficacy during a COVID-19 attack. This is also an attempt to understand the cause of severity of SARS-CoV-2 infection in diabetic patients. Until a proper cure or approved vaccine is available, it is best to manage the disease by improving the immune status and making use of already available drugs that show potential against the virus.
推荐文章
COVID-19临床资料分析
新型冠状病毒
感染
新型冠状病毒性肺炎
COVID-19疫情下方舱CT的紧急建设
新型冠状病毒肺炎
方舱CT
辐射防护
CT质量控制
儿童COVID-19的流行病学与临床诊疗特点
新型冠状病毒肺炎
儿童
流行病学
诊断治疗
COVID-19合并肺血栓栓塞症的临床特点
新型冠状病毒肺炎
新型冠状病毒
肺栓塞
预后
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Understanding the Interplay between COVID-19 and Diabetes Mellitus
来源期刊 生物科学与医学(英文) 学科 医学
关键词 COVID-19 SARS-CoV-2 Diabetes Mellitus Anti-Viral Potential of Anti-Diabetic Drugs
年,卷(期) 2020,(12) 所属期刊栏目
研究方向 页码范围 1-12
页数 12页 分类号 R58
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
COVID-19
SARS-CoV-2
Diabetes
Mellitus
Anti-Viral
Potential
of
Anti-Diabetic
Drugs
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
生物科学与医学(英文)
月刊
2327-5081
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
721
总下载数(次)
0
总被引数(次)
0
论文1v1指导